Literature DB >> 16054250

Microvolt T-wave alternans: a review of techniques, interpretation, utility, clinical studies, and future perspectives.

Majid Haghjoo1, Arash Arya, Mohammad Ali Sadr-Ameli.   

Abstract

Microvolt T-wave alternans (TWA) testing involves measuring variation in the morphology of the T-wave on an every other beat basis. The magnitude of the variation observed is typically on the order of a few microvolts. Thus in order to detect microvolt TWA, specialized recording and signal processing methods must be employed for reliable measurement. Additionally, microvolt TWA is not generally present at rest even in patients at risk of ventricular tachyarrhythmias and therefore exercise stress, pharmacologic stress, or atrial pacing must be utilized in order to elevate the heart rate. A positive MTWA test is one in which sustained TWA is present with an onset heart rate < or = 110 bpm. With current instrumentation, microvolt TWA represents an inexpensive, convenient non-invasive testing modality. Microvolt TWA has been evaluated prospectively in a variety of patient populations as a means of predicting occurrence of ventricular tachyarrhythmic events and its association with the genesis of ventricular arrhythmias has been demonstrated. Future role of microvolt TWA testing in noninvasive risk stratification is awaiting results of ongoing clinical trials. In this article, we tried to review the techniques, interpretation, indications, clinical studies, and future perspectives of microvolt TWA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054250     DOI: 10.1016/j.ijcard.2005.06.049

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators?

Authors:  K Kraaier; T McCracken; J van der Palen; A A M Wilde; M F Scholten
Journal:  Neth Heart J       Date:  2011-01       Impact factor: 2.380

2.  Comparison of quantitative T-wave alternans profiles of healthy subjects and ICD patients.

Authors:  Euler de Vilhena Garcia; Nelson Samesima; Horácio G Pereira Filho; Cristina M Quadros; Luis Tenório Cavalcante da Silva; Martino Martinelli Filho; Maria Luciana Zacharias Hannouche; Wilson Mathias; Carlos Alberto Pastore
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-04       Impact factor: 1.468

3.  Detection of T-wave alternans in fetal magnetocardiography using the generalized likelihood ratio test.

Authors:  Suhong Yu; Barry D Van Veen; Ronald T Wakai
Journal:  IEEE Trans Biomed Eng       Date:  2013-04-04       Impact factor: 4.538

4.  TWARMI pilot trial: The value and optimal criteria of microvolt T-wave alternans in the diagnosis of reversible myocardial ischemia in patients without structural cardiac disease.

Authors:  Mislav Puljevic; Ludmila Danilowicz-Szymanowicz; Giulio Molon; Davor Puljevic; Grzegorz Raczak; Guido Canali; Vedran Velagic; Borka Pezo-Nikolic; Davor Milicic
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-11-01       Impact factor: 1.468

5.  Body Surface Mapping of T-wave Alternans Depends on the Distribution of Myocardial Scarring.

Authors:  Amy Zeller; Behnaz Ghoraani
Journal:  Open Cardiovasc Med J       Date:  2015-02-27

6.  The Use of Microvolt T-Wave Alternans in Chagas Disease.

Authors:  Carlos Alberto Pastore
Journal:  Arq Bras Cardiol       Date:  2018-05       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.